PIPELINES AND RESOURCES
Click on any drug in the interactive pipeline below to learn more about drugs in development or already in use by patients.
-
Anti-Inflammatory Therapies Learn more ›
- Not Applicable
- Phase One
- Phase Two
- Phase Three
- Phase Four
- To Patients
-
Alpha-Synuclein Targeting Therapies Learn more ›
- Not Applicable
- Phase One
- Phase Two
- Phase Three
- Phase Four
- To Patients
- Affitope(R) PD01A › : To Patients ›
- Stearoyl-CoA desaturase inhibition› : To Patients ›
- Sirolimus› : To Patients ›
- FTY 720 (Fingolimod)› : To Patients ›
- BELNACASAN (VX-765)› : To Patients ›
- ATH-434 › : To Patients ›
- SynuClean-D› : To Patients ›
- Kallikrein-6› : To Patients ›
- MPLA› : To Patients ›
- BNN-20 › : To Patients ›
- BIIB101› : To Patients ›
- Lu AF82422 (alpha-synuclein mAb)› : To Patients ›
- ATH434 (formerly, PBT434 -Alterity Therapeutics)› : To Patients ›
- NBMI› : To Patients ›
-
Neuroprotective Therapies Learn more ›
- Not Applicable
- Phase One
- Phase Two
- Phase Three
- Phase Four
- To Patients
-
Diagnosis & Biomarkers Learn more ›
- Not Applicable
- Phase One
- Phase Two
- Phase Three
- Phase Four
- To Patients
- Alpha-synuclein› : To Patients ›
- Neuroimaging› : To Patients ›
- Alzheimer’s disease biomarkers› : To Patients ›
- Natural history study› : To Patients ›
- Brain network activation› : To Patients ›
- [18F]F-DOPA imaging› : To Patients ›
- Digital speech analysis (Voice4PD-MSA)› : To Patients ›
- Gait analysis› : To Patients ›
- Magnetic resonance imaging (MRI)› : To Patients ›
- Brain scans› : To Patients ›
- DaTSCAN™ Ioflupane (123l) injection/SPECT imaging› : To Patients ›
- MorphomerTM library PET tracer specific for alpha synuclein› : To Patients ›
- Transcranial magnetic stimulation (TMS)› : To Patients ›
- Web-based automated imaging (MRI)› : To Patients ›
-
Symptomatic Treatments Learn more ›
- Not Applicable
- Phase One
- Phase Two
- Phase Three
- Phase Four
- To Patients
- Ampreloxetine/TD-9855› : To Patients ›
- Atomoxetine› : To Patients ›
- Swallowing therapy› : To Patients ›
- Expiratory muscle strength training (EMST)› : To Patients ›
- Zoledronic acid › : To Patients ›
- NDMA modulator › : To Patients ›
- Safinamide› : To Patients ›
- Botulinum A toxin› : To Patients ›
- Fipamezole (JP-1730)› : To Patients ›
- Droxidopa› : To Patients ›
- Midodrine and droxidopa› : To Patients ›
- Nebivolol› : To Patients ›
- Midodrine› : To Patients ›
- Deep brain stimulation (DBS) and spinal cord stimulation (SCS)› : To Patients ›
- Transcranial direct current stimulation (tDCS)› : To Patients ›
- Transcranial magnetic stimulation (TMS)› : To Patients ›
- Abdominal binder› : To Patients ›
- Continuous positive airway pressure (CPAP) › : To Patients ›
- Brain computer interface› : To Patients ›
- Spinal cord stimulation (SCS)› : To Patients ›
- Deep brain stimulation (DBS)› : To Patients ›
- Repetitive transcranial magnetic stimulation (rTMS) and physical therapy› : To Patients ›
- Transcranial magnetic stimulation (TMS)› : To Patients ›
Stay connected with research, register on our hub:
https://defeatmsa.org/research-registry/
Please help us advocate for more therapies, donate.
DISCLAIMER: Always consult with your physician or healthcare provider team for medical advice that pertains to you. Never disregard or delay seeking medical advice due to something that you have read on our website.
LOOKING FOR OTHER WAYS TO GET INVOLVED?
JOIN THE MOVEMENT TO #DEFEATMSA
Follow us on Twitter
Follow us on Facebook
Follow us on Instagram
Follow us on YouTube
Follow us on LinkedIn
Follow us on Twitter
Follow us on Facebook
Follow us on Instagram
Follow us on LinkedIn
Follow us on YouTube
Get Involved
